Capnography Devices Market Report 2024

The capnography devices market size has grown rapidly in recent years. It will grow from $0.66 billion in 2023 to $0.74 billion in 2024 at a compound annual growth rate (CAGR) of 12%. The growth during the historic period can be attributed to the rising incidence of respiratory diseases, technological advancements, improved patient monitoring, regulatory support and guidelines, and an aging population.

The capnography devices market size is expected to see rapid growth in the next few years. It will grow to $1.17 billion in 2028 at a compound annual growth rate (CAGR) of 12.1%. The growth during the forecast period can be attributed to the rise in surgical procedures, increased awareness and training programs, supportive regulations and guidelines, and expanding applications. Key trends include higher healthcare spending, a greater focus on patient safety, expanding awareness and training initiatives, growth in home healthcare, and increased use in intensive care units (ICUs).

The increasing prevalence of respiratory diseases is anticipated to drive growth in the capnography devices market. Respiratory diseases, including asthma, chronic obstructive pulmonary disease (COPD), pneumonia, and lung cancer, impact the lungs and respiratory system, impairing breathing and potentially leading to severe health issues. Factors contributing to the rise in respiratory diseases include escalating air pollution, higher smoking rates, and aging populations. Capnography devices are crucial for monitoring and assessing ventilation status and detecting abnormalities in real time. For example, in February 2024, the Canadian Institutes of Health Research reported that respiratory illnesses were among the top 10 reasons for hospitalization, accounting for 32% of all hospitalizations for Canadians aged 0 to 4 in 2022-2023. Hospitalizations for seasonal influenza in this age group rose to 2,444, matching levels seen in 2019-2020. Lower respiratory infections saw hospital stays increase from 9,501 to 19,909, while pneumonia-related hospitalizations nearly tripled from 3,447 to 9,871. Asthma-related hospitalizations also grew significantly, rising by 61% from 3,474 to 5,607. Consequently, the growing prevalence of respiratory diseases is fueling the expansion of the capnography devices market.

Major companies in the capnography devices market are intensifying their efforts to develop advanced pilot studies to secure a competitive advantage. Pilot studies are preliminary research efforts designed to assess the feasibility, effectiveness, and potential impact of these devices in clinical environments. For example, in March 2024, TidalSense, a UK-based company specializing in respiratory devices, launched a pilot study to evaluate its innovative N-Tidal device for diagnosing asthma in young children. This study, conducted in collaboration with the University of Nottingham and Nottingham University Hospitals NHS Trust, will include 75 children under five who are experiencing asthma and viral wheezing. The N-Tidal device employs capnography technology to measure carbon dioxide levels during normal breathing, thus bypassing the need for complex spirometry tests that are often challenging for young children, potentially leading to inaccurate diagnoses and extended hospital stays.

In December 2021, ZOLL Medical Corporation, a US-based medical technology company, acquired Itamar Medical for $538 million. This acquisition enables ZOLL to utilize its global infrastructure and strong brand to drive Itamar's growth. The synergy is anticipated to improve operational efficiencies and broaden market reach, thereby offering more patients timely diagnosis and treatment options. Itamar Medical, based in Israel, specializes in capnography devices.

Major companies operating in the capnography devices market are Medtronic PLC, Becton Dickinson and Company (BD), GE HealthCare Technologies Inc., Medline Industries Inc., Philips Healthcare, Mindray Medical International Limited, Dräger, Masimo Corporation, Nihon Kohden Corporation, Spacelabs Healthcare, Vyaire Medical, ZOLL Medical Corporation, Edan Instruments Inc., Weinmann Emergency Medical Technology GmbH + Co. KG, Salter Labs Inc., MGC Diagnostics Corporation, Criticare Systems Inc., Opto Circuits Limited, Diamedica Ltd., Infinium Medical Inc.

North America was the largest region in the capnography devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the capnography devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the capnography devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Capnography devices are medical instruments designed to measure and monitor the levels of carbon dioxide (CO2) in a patient's exhaled breath. They offer real-time insights into respiratory status, aid in identifying respiratory conditions, ensure adequate ventilation, and assist in managing anesthesia during surgeries.

The primary component types of capnography devices are original equipment manufacturer (OEM) modules and other components. OEM modules are produced by one company and incorporated into final products made by another company. These devices come in hand-held, stand-alone, and multi-parameter forms and utilize technologies such as mainstream, sidestream, and microstream. Capnography devices are applied in areas including emergency medicine, pain management, procedural sedation, and critical care, among others. They are used by a range of end-users, including hospitals, ambulatory care centers, and other facilities.

The capnography devices market research report is one of a series of new reports that provides capnography devices market statistics, including capnography devices industry global market size, regional shares, competitors with a capnography devices market share, detailed capnography devices market segments, market trends and opportunities, and any further data you may need to thrive in the capnography devices industry. This capnography devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The capnography devices market consists of sales of carbon dioxide (CO2) sensors, sampling lines, and display units. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.